ScholarLens Back to search
2017•Unpublished venueRequires access

Prostate Cancer Molecular Subtyping Groups Tumors by Prognosis, Response

Dave Levitan

Open publisher page 0 citations

Abstract

Molecular subtyping of prostate cancer into three categories—luminal A, luminal B, and basal—identifies differences in prognosis and response to treatment.

About this research paper

What this paper is about

Molecular subtyping of prostate cancer into three categories—luminal A, luminal B, and basal—identifies differences in prognosis and response to treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Molecular subtyping of prostate cancer into three categories—luminal A, luminal B, and basal—identifies differences in prognosis and response to treatment.

Key concepts: Subtyping, Prostate cancer, Medicine, Oncology, Prostate, Cancer, Internal medicine, Computer science

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Prostate Cancer Molecular Subtyping Groups Tumors by Prognosis, Response — Research Paper | ScholarLens